Welcome to InGeNA’s newly-elected Board Directors

This week we held our AGM where we celebrated a year of acceleration, collaboration and impact. InGeNA has doubled in size since last year’s AGM, and the depth of engagement we’re seeing-across industry, government, research, and advocacy is growing just as fast.

Congratulations to InGeNA’s newly elected Directors:
Oliver Bonaccorso, Johnson & Johnson
David Atkins, Rhythm Biosciences
Gretchen Weightman, Oxford Nanopore Technologies
We also announced that the Board has appointed current Chair Carl Stubbings for a further term of 2 years.